Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

Published:2019-12-20 Issue:3 Volume:22 Page:417-426
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Sone Hirohito¹^ORCID,Kaneko Tatsuroh²,Shiki Kosuke²^ORCID,Tachibana Yoshifumi²,Pfarr Egon³,Lee Jisoo³,Tajima Naoko⁴

Affiliation:

1. Department of Hematology, Endocrinology and MetabolismNiigata University Graduate School of Medical and Dental Sciences Niigata Japan

2. Nippon Boehringer Ingelheim Co. Ltd. Tokyo Japan

3. Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany

4. Jikei University School of Medicine Tokyo Japan

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13909

Reference39 articles.

1. Impact of population aging on trends in diabetes prevalence: A meta‐regression analysis of 160,000 Japanese adults

2. Japanese Clinical Practice Guideline for Diabetes 2016

3. United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy

4. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

5. Long‐term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients;Shichiri M;Diabetes Care.,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview of its Chemistry, Pharmacology, and Toxicology;Current Diabetes Reviews;2024-10

2. Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;BMC Endocrine Disorders;2024-04-24

3. Assessing the Metabolic and Physical Effects of Combined DPP4 and SGLT2 Inhibitor Therapy in Patients with Type-2 Diabetes Mellitus: An Observational Prospective Pilot Study;JMA Journal;2024

4. Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2023-08-28

5. Renal, cardiovascular, and safety outcomes of adding sodium–glucose cotransporter-2 inhibitors to insulin therapy in patients with type-2 diabetes: a meta-analysis;International Urology and Nephrology;2023-07-29